Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3

Fry, Simon A.;Van den Steen, Philippe E.;Royle, Louise;Wormald, Mark R.;Rudd, Pauline M.;et.al.
(2006) Biochemistry — Vol. 45, n° 51, p. 15249-15258 (2006)

Files

No attached file found for this publication.

Details

Authors
  • Fry, Simon A.
    Author
  • Van den Steen, Philippe E.
    Author
  • Royle, Louise
    Author
  • Wormald, Mark R.
    Author
  • Rudd, Pauline M.
    Author
Show more
Abstract
Gelatinase B (MMP-9) and galectin-3 are widely known to participate in tumor cell invasion and metastasis. Glycans derived from MMP-9 expressed in MCF-7 breast cancer and THP-1 myeloid leukemia cells were compared with those from MMP-9 expressed in natural neutrophils. The many O-linked glycans of neutrophil gelatinase B presented a cluster of mainly galactosylated core II structures, 46% of which were ligands for galectin-3; 11% contained two to three N-acetyllactosamine repeating units that are high-affinity ligands for the lectin. The glycan epitopes thus provide MMP-9 with both high-affinity and (presumably) high-avidity interactions with galectin-3. In contrast, the O-glycans released from MMP-9 expressed in MCF-7 and THP-1 cells were predominantly sialylated core I structures. Only 10% of MCF-7 and THP-1 gelatinase B O-glycans were ligands for galectin-3 and contained only a maximum single N-acetyllactosamine repeat. Consistent with the glycan analysis, surface plasmon resonance binding assays indicated that the cancer-associated glycoforms of MMP-9 bound galectin-3 with an affinity and avidity significantly reduced compared with those of the natural neutrophil MMP-9. Galectin-3 exists as a multimer that also binds laminin, providing a means of localizing neutrophil MMP-9 in the extracellular matrix (ECM). The analytical data presented here suggest that MMP-9 glycoforms secreted by tumor cells are unlikely to be tethered at the site of secretion, thus promoting more extensive cleavage of the ECM and providing a rationale for the contribution that gelatinase B makes to cancer cell metastasis.
Affiliations

Citations

Fry, S. A., Van den Steen, P. E., Royle, L., Wormald, M. R., Leathem, A. J., Opdenakker, G., McDonnell, J. M., Dwek, R. A., & Rudd, P. M. (2006). Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3. Biochemistry, 45(51), 15249-15258. https://doi.org/10.1021/bi0612541 (Original work published 2006)